MyFinsight
Home
Blog
About
Cash and cash
equivalents
$330,728K
(44.98%↑ Y/Y)
Accounts receivable
$145,360K
(36.06%↑ Y/Y)
Short-term investments
$107,563K
(40.73%↑ Y/Y)
Prepaid expenses and
other current assets
$26,890K
(41.01%↑ Y/Y)
Inventory
$25,769K
(12.33%↑ Y/Y)
Total current assets
$636,310K
(40.34%↑ Y/Y)
Intangible assets, net
$247,388K
(4.00%↑ Y/Y)
Long-term investments
$123,030K
(618.97%↑ Y/Y)
Other assets
$22,244K
(225.11%↑ Y/Y)
Operating lease
right-of-use assets
$12,024K
(34.41%↑ Y/Y)
Property and equipment,
net
$2,251K
(91.25%↑ Y/Y)
Restricted cash
$1,734K
(261.25%↑ Y/Y)
Total assets
$1,044,981K
(43.97%↑ Y/Y)
Accumulated deficit
-$1,524,926K
(-129.41%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$674K
(-291.48%↓ Y/Y)
Total liabilities and
stockholders (deficit)...
$1,044,981K
(43.97%↑ Y/Y)
Total stockholders
(deficit) equity
-$10,422K
(-104.08%↓ Y/Y)
Additional paid-in capital
$1,515,172K
(64.78%↑ Y/Y)
Common stock, 0.0001
par value...
$6K
(20.00%↑ Y/Y)
Total liabilities
$1,055,403K
(124.24%↑ Y/Y)
Convertible notes payable,
net, noncurrent
$750,079K
(142.80%↑ Y/Y)
Total current
liabilities
$222,788K
(53.86%↑ Y/Y)
Holdback liabilities,
noncurrent
$61,154K
Other liabilities
$10,917K
(20.58%↑ Y/Y)
Operating lease
liabilities, noncurrent
$10,465K
(32.74%↑ Y/Y)
Accrued expenses and
other current...
$174,561K
(37.30%↑ Y/Y)
Holdback liabilities,
current
$24,800K
Accounts payable
$23,427K
(32.68%↑ Y/Y)
Back
Back
Balance Sheet
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)
source: myfinsight.com